Combined gene therapy with suicide gene and interleukin-12 is more efficient than therapy with one gene alone in a murine model of hepatocellular carcinoma
- 1 February 2000
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 32 (2) , 279-286
- https://doi.org/10.1016/s0168-8278(00)80073-2
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12Cancer Gene Therapy, 1999
- The host—tumor immune conflict: from immunosuppression to resistance and destructionImmunology Today, 1997
- Cytokines, tumour-cell death and immunogenicity: a question of choiceImmunology Today, 1997
- Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cellsNature Medicine, 1996
- IL-12: a key cytokine in immune regulationImmunology Today, 1996
- Preventing abnormalities in signal transduction of T cells in cancer: the promise of cytokine gene therapyImmunology Today, 1996
- ScienceScopeScience, 1995
- Cytokines and gene therapyImmunology Today, 1995
- Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now?Immunology Today, 1994
- Hepatocellular carcinomaJournal of Hepatology, 1992